High GGH activity has been associated with the resistance of tumour cell lines to MTX via shortening of polyglutamate chains and consequently a lower intracellular drug concentration and less inhibition of dihydrofolate reductase and TS (Rhee et al, 1993; Barnes et al, 1999). This evidence concerns the gene GGH and neoplasm.